HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology.

Abstract
Chlamydial infections represent a major threat to the long-term survival of the koala and a successful vaccine would provide a valuable management tool. Vaccination however has the potential to enhance inflammatory disease in animals exposed to a natural infection prior to vaccination, a finding in early human and primate trials of whole cell vaccines to prevent trachoma. In the present study, we vaccinated both healthy koalas as well as clinically diseased koalas with a multi-subunit vaccine consisting of Chlamydia pecorum MOMP and NrdB mixed with immune stimulating complex as adjuvant. Following vaccination, there was no increase in inflammatory pathological changes in animals previously infected with Chlamydia. Strong antibody (including neutralizing antibodies) and lymphocyte proliferation responses were recorded in all vaccinated koalas, both healthy and clinically diseased. Vaccine induced antibodies specific for both vaccine antigens were observed not only in plasma but also in ocular secretions. Our data shows that an experimental chlamydial vaccine is safe to use in previously infected koalas, in that it does not worsen infection-associated lesions. Furthermore, the prototype vaccine is effective, as demonstrated by strong levels of neutralizing antibody and lymphocyte proliferation responses in both healthy and clinically diseased koalas. Collectively, this work illustrates the feasibility of developing a safe and effective Chlamydia vaccine as a tool for management of disease in wild koalas.
AuthorsAvinash Kollipara, Carmel George, Jon Hanger, Jo Loader, Adam Polkinghorne, Kenneth Beagley, Peter Timms
JournalVaccine (Vaccine) Vol. 30 Issue 10 Pg. 1875-85 (Feb 27 2012) ISSN: 1873-2518 [Electronic] Netherlands
PMID22230583 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Bacterial
  • Antibodies, Neutralizing
  • Bacterial Outer Membrane Proteins
  • Bacterial Vaccines
  • ISCOMs
  • Vaccines, Subunit
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Animals
  • Antibodies, Bacterial (blood)
  • Antibodies, Neutralizing (blood)
  • Bacterial Outer Membrane Proteins (administration & dosage, immunology)
  • Bacterial Vaccines (administration & dosage, immunology)
  • Chlamydia (immunology, pathogenicity)
  • Chlamydia Infections (pathology, prevention & control, veterinary)
  • Cross Reactions
  • Eye (immunology)
  • Female
  • ISCOMs (administration & dosage)
  • Keratoconjunctivitis, Infectious (immunology, microbiology)
  • Male
  • Phascolarctidae (immunology, microbiology)
  • Urogenital System (microbiology)
  • Vaccines, Subunit (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: